Biography:
Dr. Jason Beckwith is SVP, Talent Science & Predictive Analytics at BioTalent Ltd (part of The IN Group) and a leading authority in biopharmaceutical workforce analytics, as well as the creator of the Talent Efficiency (TE) and Biopharma Talent Index (BTI) frameworks. Drawing on research conducted at the University of Dundee, University College London, and across more than four hundred global biopharma sites, he applies quantitative modelling, complexity science, and predictive analytics to human capital strategy, enabling organisations to link workforce performance directly to operational reliability, digital transformation outcomes, and enterprise value. Integrating methods including Monte Carlo simulation, Bayesian inference, synchrony modelling, frontier analysis, network optimisation, and workforce Value-at-Risk (WVaR), he quantifies capability alignment, stability, drag, volatility, and transformation readiness with a level of precision not achieved by traditional HR analytics. With over 30 years of international experience across biotech, pharma, CDMO, and advanced therapy organisations, Dr. Beckwith has advised global leadership teams on capability design, AI and automation strategy, post-merger integration, site transformation, and workforce engineering. His work has appeared in BioProcess International, GEN, and other industry publications, and he is frequently invited to speak at BPI Boardroom, CPhI, The Economist, DCAT, BIO, NIBRT, and ATMP-focused events. At BioTalent, he leads the firm’s Talent Science & Predictive Analytics practice, supporting CHROs, COOs, and CFOs in building future-ready workforces, reducing operational risk, and accelerating technology adoption.


Title : The science of longevity delivery: Why capability, not biology, determines outcomes